JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$3.85B |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$1.5B |
| 3 |
JPMorgan BetaBuilders Canada ETF
BBCA
|
+$1.21B |
| 4 |
Chevron
CVX
|
+$1.08B |
| 5 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$986M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$3.61B |
| 2 |
Occidental Petroleum
OXY
|
+$1.36B |
| 3 |
Merck
MRK
|
+$913M |
| 4 |
Visa
V
|
+$801M |
| 5 |
AT&T
T
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.9% |
| 2 | Financials | 12.36% |
| 3 | Healthcare | 9.31% |
| 4 | Consumer Discretionary | 8.69% |
| 5 | Industrials | 6.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GSV
3026
DELISTED
Gold Standard Ventures Corp.
GSV
| $2.73M | ﹤0.01% |
2,572,730
-119,782
| -4% | -$125K |
|
3027
CALL
Genuine Parts
GPC
$18.5B
| $2.73M | ﹤0.01% |
26,500
+3,000
| +13% | +$311K |
|
3028
PUT
Pinterest
PINS
$13.6B
| $2.72M | ﹤0.01% |
+100,000
| New | +$2.73M |
|
3029
Resideo Technologies
REZI
$3.13B
| $2.71M | ﹤0.01% |
128,464
-28,924
| -18% | -$611K |
|
|
JCAP
3030
DELISTED
Jernigan Capital, Inc.
JCAP
| $2.71M | ﹤0.01% |
129,196
-3,566
| -3% | -$75.1K |
|
3031
Arlo Technologies
ARLO
$1.55B
| $2.7M | ﹤0.01% |
682,801
-55,074
| -7% | -$216K |
|
3032
Santander
BSBR
$43B
| $2.7M | ﹤0.01% |
237,992
-97,590
| -29% | -$1.06M |
|
3033
CALL
Zscaler
ZS
$29.9B
| $2.7M | ﹤0.01% |
+34,800
| New | +$2.48M |
|
3034
CALL
DXC Technology
DXC
$1.74B
| $2.69M | ﹤0.01% |
+50,000
| New | +$2.89M |
|
|
UHT
3035
Universal Health Realty Income Trust
UHT
$571M
| $2.69M | ﹤0.01% |
32,032
+12,689
| +66% | +$1.04M |
|
|
GOGL
3036
DELISTED
Golden Ocean Group
GOGL
| $2.69M | ﹤0.01% |
472,140
+246,060
| +109% | +$1.29M |
|
3037
Independence Realty Trust
IRT
$4B
| $2.68M | ﹤0.01% |
233,328
+46,174
| +25% | +$507K |
|
3038
Markel Group
MKL
$22.9B
| $2.68M | ﹤0.01% |
2,501
+1,000
| +67% | +$1.05M |
|
3039
Greenlight Captial
GLRE
$512M
| $2.67M | ﹤0.01% |
316,146
-94,445
| -23% | -$972K |
|
|
ITCI
3040
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $2.67M | ﹤0.01% |
210,531
-7,045
| -3% | -$90.4K |
|
3041
Cactus
WHD
$5.92B
| $2.67M | ﹤0.01% |
84,036
+31,556
| +60% | +$1.1M |
|
3042
Adtran
ADTN
$671M
| $2.67M | ﹤0.01% |
176,861
-193,128
| -52% | -$3.08M |
|
3043
Usana Health Sciences
USNA
$248M
| $2.67M | ﹤0.01% |
34,781
-77,123
| -69% | -$6.12M |
|
3044
CALL
ASML
ASML
$700B
| $2.67M | ﹤0.01% |
13,000
| – | – |
|
|
3045
PUT
ASML
ASML
$700B
| $2.67M | ﹤0.01% |
13,000
| – | – |
|
3046
Eldorado Gold
EGO
$10.3B
| $2.66M | ﹤0.01% |
463,045
+461,520
| +30,264% | +$1.95M |
|
3047
Ligand Pharmaceuticals
LGND
$5.87B
| $2.66M | ﹤0.01% |
37,403
-1,572
| -4% | -$116K |
|
3048
SITE Centers
SITC
$155M
| $2.66M | ﹤0.01% |
259,680
+48,209
| +23% | +$505K |
|
3049
Cooper-Standard Automotive
CPS
$501M
| $2.65M | ﹤0.01% |
59,069
+6,610
| +13% | +$315K |
|
3050
Sensata Technologies
ST
$6.68B
| $2.65M | ﹤0.01% |
54,391
-6,858
| -11% | -$326K |
|
Similar funds
JP Morgan Chase's Q2 2019 Portfolio in Review
As of Q2 2019, JP Morgan Chase held 6,226 positions worth $511B, up 4.5% from $490B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase's Q2 2019 filing shows 458 new, 2,669 increased, 2,117 reduced and 420 closed positions. Its largest new stake was Corteva: 13,119,143 shares worth $388M. The largest sale was iShares 1-3 Year Treasury Bond ETF, an estimated $3.61B.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Healthcare.
- JP Morgan Chase's largest Q2 2019 buy was Corteva: 13,119,143 shares worth $388M.
- JP Morgan Chase added most to iShares 0-1 Year Treasury Bond ETF in Q2 2019, an estimated $3.85B increase.
- JP Morgan Chase's biggest Q2 2019 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.61B.
- JP Morgan Chase fully exited Goldcorp Inc in Q2 2019, selling an estimated $131M.
- JP Morgan Chase's ten largest holdings make up 16% of its $511B portfolio in Q2 2019.
- JP Morgan Chase opened 458 new positions and closed 420 in Q2 2019.
- JP Morgan Chase's portfolio value rose 4.5% quarter-over-quarter to $511B.
Based on JP Morgan Chase's 13F filing for Q2 2019, filed 7 Aug 2019.